Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Young adults 16-21 years of age at diagnosis entered on Childrens Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Results of treatment.
Nachman J, Sather HN, Buckley JD, Gaynon PS, Steinherz PG, Tubergen DG, Lampkin BC, Hammond GD. Nachman J, et al. Among authors: sather hn. Cancer. 1993 May 15;71(10 Suppl):3377-85. doi: 10.1002/1097-0142(19930515)71:10+<3377::aid-cncr2820711741>3.0.co;2-8. Cancer. 1993. PMID: 8490886 Clinical Trial.
Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features. Report of Children's Cancer Study Group Study CCG-193P.
Gaynon PS, Bleyer WA, Steinherz PG, Finklestein JZ, Littman PS, Miller DR, Reaman GH, Sather HN, Hammond GD. Gaynon PS, et al. Among authors: sather hn. Am J Pediatr Hematol Oncol. 1988 Spring;10(1):42-50. doi: 10.1097/00043426-198821000-00009. Am J Pediatr Hematol Oncol. 1988. PMID: 3056061 Clinical Trial.
Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.
Nachman J, Sather HN, Gaynon PS, Lukens JN, Wolff L, Trigg ME. Nachman J, et al. Among authors: sather hn. J Clin Oncol. 1997 Jun;15(6):2222-30. doi: 10.1200/JCO.1997.15.6.2222. J Clin Oncol. 1997. PMID: 9196134 Clinical Trial.
Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.
Steinherz PG, Gaynon PS, Breneman JC, Cherlow JM, Grossman NJ, Kersey JH, Johnstone HS, Sather HN, Trigg ME, Uckun FM, Bleyer WA. Steinherz PG, et al. Among authors: sather hn. Cancer. 1998 Feb 1;82(3):600-12. doi: 10.1002/(sici)1097-0142(19980201)82:3<600::aid-cncr24>3.0.co;2-4. Cancer. 1998. PMID: 9452280 Clinical Trial.
199 results